Icecure Medical Stock Return On Equity
| ICCM Stock | USD 0.84 0.03 3.70% |
Icecure Medical fundamentals help investors to digest information that contributes to Icecure Medical's financial success or failures. It also enables traders to predict the movement of Icecure Stock. The fundamental analysis module provides a way to measure Icecure Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Icecure Medical stock.
| Last Reported | Projected for Next Year | ||
| Return On Equity | (1.20) | (1.14) |
Icecure | Return On Equity |
Icecure Medical Company Return On Equity Analysis
Icecure Medical's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Icecure Medical Return On Equity | -0.94 |
Most of Icecure Medical's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Icecure Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Icecure Return On Equity Driver Correlations
Understanding the fundamental principles of building solid financial models for Icecure Medical is extremely important. It helps to project a fair market value of Icecure Stock properly, considering its historical fundamentals such as Return On Equity. Since Icecure Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Icecure Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Icecure Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Icecure Total Stockholder Equity
Total Stockholder Equity |
|
Based on the latest financial disclosure, Icecure Medical has a Return On Equity of -0.9422. This is 96.07% lower than that of the Health Care Equipment & Supplies sector and 89.21% lower than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.
Icecure Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Icecure Medical's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Icecure Medical could also be used in its relative valuation, which is a method of valuing Icecure Medical by comparing valuation metrics of similar companies.Icecure Medical is currently under evaluation in return on equity category among its peers.
Icecure Medical Current Valuation Drivers
We derive many important indicators used in calculating different scores of Icecure Medical from analyzing Icecure Medical's financial statements. These drivers represent accounts that assess Icecure Medical's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Icecure Medical's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 148.5M | 186.7M | 87.1M | 57.4M | 48.8M | 60.9M | |
| Enterprise Value | 142.9M | 183.5M | 62.4M | 34.3M | 38.9M | 60.0M |
Icecure Fundamentals
| Return On Equity | -0.94 | ||||
| Return On Asset | -0.47 | ||||
| Operating Margin | (3.19) % | ||||
| Current Valuation | 35.33 M | ||||
| Shares Outstanding | 55.5 M | ||||
| Shares Owned By Insiders | 54.17 % | ||||
| Shares Owned By Institutions | 0.39 % | ||||
| Number Of Shares Shorted | 2.31 M | ||||
| Price To Book | 4.52 X | ||||
| Price To Sales | 13.64 X | ||||
| Revenue | 3.23 M | ||||
| Gross Profit | 1.45 M | ||||
| EBITDA | (15.25 M) | ||||
| Net Income | (14.65 M) | ||||
| Cash And Equivalents | 17.73 M | ||||
| Cash Per Share | 0.48 X | ||||
| Total Debt | 599 K | ||||
| Debt To Equity | 0.04 % | ||||
| Current Ratio | 4.99 X | ||||
| Book Value Per Share | 0.27 X | ||||
| Cash Flow From Operations | (12.52 M) | ||||
| Short Ratio | 0.46 X | ||||
| Earnings Per Share | (0.28) X | ||||
| Target Price | 3.37 | ||||
| Number Of Employees | 71 | ||||
| Beta | 2.63 | ||||
| Market Capitalization | 45.51 M | ||||
| Total Asset | 16.41 M | ||||
| Retained Earnings | (90.06 M) | ||||
| Working Capital | 10.31 M | ||||
| Net Asset | 16.41 M |
About Icecure Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Icecure Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Icecure Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Icecure Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Icecure Medical Piotroski F Score and Icecure Medical Altman Z Score analysis. To learn how to invest in Icecure Stock, please use our How to Invest in Icecure Medical guide.You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Icecure Medical. If investors know Icecure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Icecure Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.28) | Revenue Per Share 0.071 | Quarterly Revenue Growth 0.079 | Return On Assets (0.47) | Return On Equity (0.94) |
The market value of Icecure Medical is measured differently than its book value, which is the value of Icecure that is recorded on the company's balance sheet. Investors also form their own opinion of Icecure Medical's value that differs from its market value or its book value, called intrinsic value, which is Icecure Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Icecure Medical's market value can be influenced by many factors that don't directly affect Icecure Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Icecure Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Icecure Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Icecure Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.